<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Strukturierte Produkte
>
08.06.2015 17:35:47

Resverlogix Reports on the Beneficial Effects of RVX-208 on Glucose Metabolism in Prediabetes Mellitus at the American Diabetes Association's (ADA) Scientific Sessions in Boston, MA

TSX Exchange Symbol: RVXCALGARY, June 8, 2015 /CNW/ - Resverlogix Corp. (TSX: RVX) today announced that findings of a study performed by the Baker IDI Heart and Diabetes Institute, Melbourne, A...

Weiter zum vollständigen Artikel bei "CNX Marketlink"